Print page
E-mail page
Download PDF
« Previous Release | Next Release »
HAMILTON, Bermuda, Sept 27, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) will host a brief conference call on Wednesday, September 27, 2006 beginning at 8:30 AM (ET) to address the Company's response to the announcement by Barr Pharmaceuticals, Inc. that it intends to launch a generic version of Ovcon(R) 35. The conference call will be open to all interested parties. The number to call within the United States is (800) 894-5910. Participants outside the United States should call (785) 424-1052. The conference call access code is 86524. A replay of the conference call will be available from September 27, 2006 through October 11, 2006 and can be accessed by dialing (888) 215-1533 from within the United States or (402) 220-4939 from outside the United States.
The Company
Warner Chilcott is a leading specialty pharmaceutical company focused on marketing, selling, developing and manufacturing branded prescription products in women's healthcare and dermatology in the United States.
SOURCE Warner Chilcott Limited
Paul Herendeen, Chief Financial Officer of Warner Chilcott, +1-973-442-3200, pherendeen@wcrx.com
http://www.prnewswire.com
Copyright (C) 2006 PR Newswire. All rights reserved.
News Provided by COMTEX
